Such was confirmation of this holy, hairy topic. Consider this hair study as a companion piece to “What the Bible Says About ...

In this phase 2 study, the primary objective was to assess ARV-110 antitumor activity. As of a data cut-off of December 20, 2021, 195 patients had been enrolled, including 71 in phase 1 and 124 in ...

Who remembers driver’s education classes? It was one class that came with a reward. I recall the excitement everyone shared in class about one day obtaining their own driver’s licenses. A license ...

AI is transforming every industry, from medicine to film to finance. So, why not use it to study one of the world's most revered ancient texts, the Bible?

In the 1/1.5 mg/kg dose group, median OS achieved 17.5 months, suggesting the potential long-term survival benefit of IBI363 as a PD-1/IL-2 α-bias bispecific immunotherapy.

SAN FRANCISCO, CA, USA and SUZHOU, China I June 2, 2025 I Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...